12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

NCT00240435 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

491

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DEVICE: 5 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler
DEVICE: 10 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler

Sponsor

Boehringer Ingelheim